Sequenom Center For Molecular Medicine LLC - MI Kent, Grand Rapids 49503

Sequenom Center For Molecular Medicine LLC entered the industry of Medical Labs in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000.000 to $99.999.999. The NAICS classifies this business under the code 621511, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.

To acquire more information, please contact Paul V Maier by calling (858) 202-9000 during business hours. You can also write to the business’ Single Location at 301 Michign St Ne # 580, Grand Rapids, Michigan MI 49503. You can also visit the company’s website at sequenom.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Sequenom Center For Molecular Medicine LLC
Representative: Paul V Maier
Place of Business: 301 Michign St Ne # 580, Grand Rapids, MI 49503
Contact Number: (858) 202-9000
Website: sequenom.com
Type of Service: Medical Labs
SIC Number: 8071
NAICS Number: 621511
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2008
Income/Year: $50.000.000 to $99.999.999
Laborers: 1 to 4
Share This Company:

Sequenom Center For Molecular Medicine LLC is a company operating from Kent, Michigan providing professional Medical Labs and relevant B2C variables. It was founded in 2008 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 621511 as Medical Labs.

With a current employee count of 1 to 4, Sequenom Center For Molecular Medicine LLC has gone to report making $50.000.000 to $99.999.999 per annum on its journey towards growth. This company invites you to contact its representative Paul V Maier at (858) 202-9000 for related queries, or to locate its Single Location using the coordinates 42.970443,-85.661738.

The Single Location can also be found at the street address 301 Michign St Ne # 580 in Grand Rapids, Michigan 49503 and can be engaged online through the company website at sequenom.com, the company Twitter , and Facebook page .